Jay M. Short - Jun 21, 2022 Form 4 Insider Report for BioAtla, Inc. (BCAB)

Role
Chief Executive Officer, Director, 10%+ Owner
Signature
/s/ Christian Vasquez, as Attorney-in-Fact for Jay M. Short
Stock symbol
BCAB
Transactions as of
Jun 21, 2022
Transactions value $
$198,336
Form type
4
Date filed
6/23/2022, 04:59 PM
Previous filing
May 6, 2022
Next filing
Jul 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCAB Common Stock Purchase $81K +29.1K +2.23% $2.79 1.34M Jun 21, 2022 Direct F1, F2
transaction BCAB Common Stock Purchase $117K +40.3K +3.02% $2.91 1.38M Jun 22, 2022 Direct F1, F3
holding BCAB Common Stock 794K Jun 21, 2022 By Spouse
holding BCAB Common Stock 259K Jun 21, 2022 By Carolyn Short 2020 Irrevocable Gift Trust
holding BCAB Common Stock 259K Jun 21, 2022 By Jay Short 2020 Irrevocable Gift Trust
holding BCAB Common Stock 302K Jun 21, 2022 By Capia IP, LLC
holding BCAB Common Stock 50 Jun 21, 2022 By Himalaya Parent LLC F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
F2 The range of prices for the shares of Common Stock is from $2.68 to $2.87. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F3 The range of prices for the shares of Common Stock is from $2.70 to $3.02. The Reporting Person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price.
F4 The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.